224 related articles for article (PubMed ID: 12488407)
1. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer.
Du XL; Osborne C; Goodwin JS
J Clin Oncol; 2002 Dec; 20(24):4636-42. PubMed ID: 12488407
[TBL] [Abstract][Full Text] [Related]
2. Risk of hospitalizations associated with adverse effects of chemotherapy in a large community-based cohort of elderly women with ovarian cancer.
Nurgalieva Z; Liu CC; Du XL
Int J Gynecol Cancer; 2009 Nov; 19(8):1314-21. PubMed ID: 20009883
[TBL] [Abstract][Full Text] [Related]
3. Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity.
Du XL; Chan W; Giordano S; Geraci JM; Delclos GL; Burau K; Fang S
Cancer; 2005 Sep; 104(5):913-24. PubMed ID: 15991239
[TBL] [Abstract][Full Text] [Related]
4. Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy.
Freedman RA; Vaz-Luis I; Barry WT; Lii H; Lin NU; Winer EP; Keating NL
Breast Cancer Res Treat; 2014 Jun; 145(2):491-501. PubMed ID: 24756187
[TBL] [Abstract][Full Text] [Related]
5. Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States).
Chen-Hardee S; Chrischilles EA; Voelker MD; Brooks JM; Scott S; Link BK; Delgado D
Cancer Causes Control; 2006 Jun; 17(5):647-54. PubMed ID: 16633911
[TBL] [Abstract][Full Text] [Related]
6. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.
Du X; Goodwin JS
J Clin Oncol; 2001 Mar; 19(5):1455-61. PubMed ID: 11230491
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the association between adjuvant chemotherapy and function-related adverse events among older patients with early stage breast cancer.
Mariano C; Lund JL; Peacock Hinton S; Htoo P; Muss H; Reeder-Hayes KE
J Geriatr Oncol; 2017 Jul; 8(4):242-248. PubMed ID: 28601373
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer.
Nurgalieva Z; Liu CC; Du XL
Med Oncol; 2011 Sep; 28(3):716-25. PubMed ID: 20361359
[TBL] [Abstract][Full Text] [Related]
9. Hospitalization by cytotoxic chemotherapy regimen among older women with stage IV breast cancer.
Kehl KL; Niu J; Chavez-MacGregor M; Giordano SH
Cancer; 2018 Dec; 124(24):4685-4691. PubMed ID: 30264853
[TBL] [Abstract][Full Text] [Related]
10. Association between Concomitant Use of Hydrochlorothiazide and Adverse Chemotherapy-Related Events among Older Women with Breast Cancer Treated with Cyclophosphamide.
Hsu CD; Hinton SP; Reeder-Hayes KE; Sanoff HK; Lund JL
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):520-523. PubMed ID: 31871107
[TBL] [Abstract][Full Text] [Related]
11. Mammography use, breast cancer stage at diagnosis, and survival among older women.
McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
[TBL] [Abstract][Full Text] [Related]
12. Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer.
Winn AN; Check DK; Farkas A; Fergestrom NM; Neuner JM; Roberts AW
JAMA Netw Open; 2020 Sep; 3(9):e2016858. PubMed ID: 32930779
[TBL] [Abstract][Full Text] [Related]
13. Surveillance for hospitalizations with infection-related diagnoses after chemotherapy among breast cancer patients diagnosed before age 65.
Polednak AP
Chemotherapy; 2004 Oct; 50(4):157-61. PubMed ID: 15347907
[TBL] [Abstract][Full Text] [Related]
14. Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy.
Lu-Yao G; Nightingale G; Nikita N; Keith S; Gandhi K; Swartz K; Zinner R; Sharma S; Kelly WMK; Chapman A
J Geriatr Oncol; 2020 May; 11(4):579-585. PubMed ID: 32199776
[TBL] [Abstract][Full Text] [Related]
15. CMF-regimen preferred as first-course chemotherapy for older and sicker women with breast cancer: Findings from a SEER-Medicare-based population study.
Kadakia A; Rajan SS; Abughosh S; Du XL; Johnson ML
Am J Clin Oncol; 2015 Apr; 38(2):165-73. PubMed ID: 23608830
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
17. Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer.
Li S; Liu J; Virnig BA; Collins AJ
Breast Cancer Res Treat; 2017 Feb; 161(3):515-524. PubMed ID: 27933451
[TBL] [Abstract][Full Text] [Related]
18. Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy.
Heck JE; Albert SM; Franco R; Gorin SS
J Am Geriatr Soc; 2008 Sep; 56(9):1687-92. PubMed ID: 18691280
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.
Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS
J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916
[TBL] [Abstract][Full Text] [Related]
20. Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).
Lamont EB; Yu M; He Y; Saltz L; Muss H; Zaslavsky AM;
J Geriatr Oncol; 2014 Jul; 5(3):230-7. PubMed ID: 24594119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
